Efficacy of a combined oral contraceptive containing 0.030 mg ethinylestradiol/2 mg dienogest for the treatment of papulopustular acne in comparison with placebo and 0.035 mg ethinylestradiol/2 mg cyproterone acetate☆
To access this article, please choose from the options below
☆ This study was funded by Schering (Berlin, Germany; now Bayer Schering Pharma).
PII: S0010-7824(08)00491-5
doi:10.1016/j.contraception.2008.10.010
© 2009 Elsevier Inc. All rights reserved.
